<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01126437</url>
  </required_header>
  <id_info>
    <org_study_id>205.452</org_study_id>
    <secondary_id>2009-015713-51</secondary_id>
    <nct_id>NCT01126437</nct_id>
  </id_info>
  <brief_title>Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease</brief_title>
  <official_title>A Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Design, Multi-center Trial to Compare the Efficacy and Safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution Delivered by the Respimat Inhaler With Tiotropium Inhalation Capsules 18 µg Delivered by the HandiHaler (TIOSPIR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <brief_summary>
    <textblock>
      Direct comparison studies of the tiotropium HandiHaler® 18 µg and Respimat® 5 µg formulations
      have been limited to 4-week crossover studies. Therefore, prospective data from a trial of
      adequate size and duration is required to establish that compared to tiotropium HandiHaler®,
      tiotropium Respimat® will have (a) similar effects on safety and (b) similar or superior
      effects on exacerbations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to All-Cause Mortality</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Number of patients with all-cause mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to First COPD Exacerbation</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).
&quot;Onset of exacerbation&quot; was defined by the onset of first recorded symptom. The &quot;end of exacerbation&quot; was decided by the investigator based on clinical judgement.
Exacerbations were classified as follows:
Mild:a new prescription of maintenance bronchodilator only Moderate:antibiotics or systemic steroids without hospitalization Severe:hospitalization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Trough FEV1 Over 120 Weeks (in a Substudy of 1370 Patients)</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Trough forced expiratory volume in one second (FEV1) over 120 weeks (in a substudy of 1370 patients)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of COPD Exacerbations</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>The number of COPD exacerbations. COPD exacerbation defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Hospitalization Associated With COPD Exacerbation</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>The results presented below are for the patients with hospitalizations due to COPD exacerbations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Hospitalizations Associated With COPD Exacerbation</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Total number of hospitalizations associated with COPD exacerbation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Moderate to Severe COPD Exacerbation</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>COPD exacerbation defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).
Exacerbations classified as follows:
Mild:a new prescription of maintenance bronchodilator only Moderate:antibiotics or systemic steroids without hospitalization Severe:hospitalization.
Results presented below are number of patients with moderate to severe exacerbations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Onset of First Major Adverse Cardiovascular Event (MACE)</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Time to onset of first major adverse cardiovascular event (MACE). MACE was defined as: Fatal event in the system organ classes of cardiac and vascular disorders, Preferred terms: sudden death, cardiac death, sudden cardiac death, Outcome events of myocardial infarction (serious and non-serious), Outcome events of stroke (serious and non-serious) and Outcome events of TIA (serious and non-serious). The results presented below are for the number of patients with MACE.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Death From Major Adverse Cardiovascular Event (MACE)</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>The results presented below are number of patients with death from MACE.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">17183</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>tiotropium 2.5 mcg and placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive one of the active tiotropium arms daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tiotropium 18 mcg and placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive one of the active tiotropium arms daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tiotropium 5 mcg and placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive one of the active tiotropium arms daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tiotropium 18 mcg</intervention_name>
    <description>HandiHaler</description>
    <arm_group_label>tiotropium 18 mcg and placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tiotropium 1.25 mcg (2 actuations/day)</intervention_name>
    <description>soft mist inhaler 2 actuations=2 puffs/day</description>
    <arm_group_label>tiotropium 2.5 mcg and placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tiotropium 2.5 mcg (2 actuations/day)</intervention_name>
    <description>soft mist inhaler (2 actuations=2 puffs/day)</description>
    <arm_group_label>tiotropium 5 mcg and placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. All patients must sign an informed consent consistent with International Conference on
             Harmonization Good Clinical Practice (ICH-GCP) guidelines prior to participation in
             the trial, which includes medication washout and restrictions.

          2. Male or female patients 40 years of age or older.

          3. Patients must be current or ex-smokers with a smoking history of ≥10 pack-years.
             (Patients who have never smoked cigarettes must be excluded)

          4. All patients must have a diagnosis of COPD (P06-12085), and must meet the following
             criteria: Relatively stable airway obstruction with a post-bronchodilator FEV1 ≤ 70%
             of predicted normal and post-bronchodilator FEV1 / FVC ≤70%.

             Pulmonary function tests (PFTs) were conducted after the inhalation of 400 μg
             salbutamol / albuterol (preferred), however testing with either 200 μg
             salbutamol/albuterol or a combination of salbutamol / albuterol with ipratropium
             bromide (2 to 4 actuations) was acceptable. Other short-acting beta agonists, such as
             terbutaline, may have been used for the testing. The medication used for the testing
             was documented. Further, historical data from measurements within the past 6 months
             either at the site or at a referral site may have been used (see Section 6.2.1 of the
             CTP, located in Appendix 16.1.1). Subjects were not to have been randomized to the
             study without the availability of spirometry data at the actual study site.

             Eligibility for PFT sub-study: For subjects participating in the spirometry sub-study,
             historical data may not have been used for inclusion. These subjects must have
             qualified in the clinic at Visit 1 after performing a baseline measurement. These
             subjects performed a pre-dose PFT which was followed by the administration of 400 μg
             salbutamol / albuterol only (no other short-acting beta agonist was allowed), followed
             by a post-dose PFT for qualification.

          5. Able to inhale from the HandiHaler® and the Respimat® devices.

        Exclusion criteria:

          1. Significant diseases other than COPD. A significant disease is defined as a disease or
             condition which, in the opinion of the investigator, may put the patient at risk
             because of participation in the study or may influence the patients ability to
             participate in the study.

          2. Patients with a recent history (i.e., six months or less) of myocardial infarction.

          3. Patients with any unstable or life-threatening cardiac arrhythmia requiring
             intervention or change in drug therapy during the last year.

          4. Hospitalisation for cardiac failure (New York Heart Association (NYHA) Class III or
             IV) during the past year.

          5. Known active tuberculosis.

          6. Patients with a history of asthma, cystic fibrosis, clinically evident bronchiectasis,
             interstitial lung disease, or pulmonary thromboembolic disease.

          7. History of thoracotomy with pulmonary resection. Subjects with a history of
             thoracotomy for other reasons were to have been evaluated per exclusion criterion 1.

          8. Subject was planning to undergo lung transplant or lung volume reduction surgery
             (LVRS).

          9. Malignancy for which the subject had undergone resection, radiation, chemotherapy or
             biological treatments within the last 5 years. Subjects with treated basal cell
             carcinoma were allowed.

         10. Known respiratory infection or exacerbation of COPD in the 4 weeks prior to
             randomization.

         11. Known hypersensitivity to anticholinergic drugs, lactose, benzalkonium chloride (BAC),
             ethylenediaminetetraacetic acid (EDTA), or any other components of the HandiHaler® or
             Respimat® inhalation solution delivery system.

         12. Known moderate to severe renal impairment (as judged by the investigator).

         13. Known narrow angle glaucoma.

         14. Known significant symptomatic prostatic hyperplasia or bladder-neck obstruction.
             Subjects whose symptoms were controlled on treatment may have been included.

         15. Use of systemic corticosteroid medication at unstable doses (i.e., less than 6 weeks
             on stable dose) or at doses in excess of the equivalent of 10 mg prednisolone per day.

         16. Pregnant or nursing women or women of childbearing potential not using a medically
             approved means of contraception for at least 3 months prior to and for the duration of
             the trial.

         17. Significant alcohol or drug abuse within the past 12 months.

         18. Subjects requiring the use of supplemental oxygen therapy for &gt; 12 hours per day.

         19. Subjects who had completed a pulmonary rehabilitation program in the 6 weeks prior to
             the screening visit or subjects who were currently in a pulmonary rehabilitation
             program that was not maintained throughout the duration of the study.

         20. Subjects who had taken an investigational drug within 30 days prior to the Screening
             Visit.

         21. Previous participation (receipt of randomized treatment) in this study.

         22. Subjects who were currently participating in an interventional study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boehringer Ingelheim</last_name>
    <role>Study Chair</role>
    <affiliation>Boehringer Ingelheim</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>205.452.01107 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Athens</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01035 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01052 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01219 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01227 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01280 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01198 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Florence</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01244 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01041 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Montgomery</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01070 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01218 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01175 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01200 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01317 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01350 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pheonix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01254 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01283 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01315 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01158 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01161 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01302 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01038 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Encinitas</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01313 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01375 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01074 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01345 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lancaster</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01171 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lincoln</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01339 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lomita</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01298 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01356 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01148 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01111 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01147 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paramount</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01071 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Poway</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01089 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rancho Cucamonga</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01097 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Redlands</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01078 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01176 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01346 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01306 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01297 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01362 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01225 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Victorville</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01224 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01236 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wildomar</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01049 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01245 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01351 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wheat Ridge</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wheat Ridge</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01199 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Danbury</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01054 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01072 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01040 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01109 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Waterbury</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01308 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01209 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01360 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Homestead</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01241 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01337 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01343 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01184 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01138 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01246 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01321 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01290 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01203 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01174 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01135 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01173 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oviedo</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01195 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Panama City</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01197 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Panama City</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01239 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01247 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01286 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01240 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01260 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ponte Vedra</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01092 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rockledge</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01251 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01133 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01136 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01207 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01134 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tamarac</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01231 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tamarac</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01250 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01060 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01130 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01047 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Austell</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01255 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Conyers</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01299 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01288 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01090 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Snellville</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01100 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01165 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01059 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coeur d'Alene</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01062 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Eagle</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01166 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hayden Lake</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01275 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Meridian</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01330 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01248 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Belleville</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01278 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01371 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Downer Grove</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01235 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lombard</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01180 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>O'Fallon</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01268 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oak Park</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01359 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quincy</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01347 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brownsburg</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01153 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01301 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fishers</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01141 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Franklin</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01137 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lafayette</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01263 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Muncie</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01284 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Council Bluffs</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dubuque</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01305 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lansing</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01304 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Olathe</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01125 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01068 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01063 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bowling Green</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01206 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Mitchell</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01289 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01152 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paducah</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01091 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01329 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01364 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Auburn</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01169 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Biddeford</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01053 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01190 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Elkridge</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01336 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hollywood</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01238 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01243 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01366 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01269 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01208 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Bedford</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01170 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01270 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01349 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Benzonia</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01365 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chelsea</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01149 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chesterfield</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01146 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01139 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Interlochen</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01080 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01310 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Stevensville</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01122 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Traverse City</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01081 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01221 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01205 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chaska</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01211 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01104 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fridley</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01113 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01042 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Olive Branch</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01129 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Charles</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01110 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01179 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>West Plains</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01226 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01076 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Butte</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01196 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01150 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bellevue</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01187 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fremont</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01155 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01073 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01261 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01369 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newington</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01296 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ocean</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01046 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Toms River</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01061 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01167 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01159 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bayside</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01163 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bronxville</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01194 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cooperstown</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01131 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Elmira</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01142 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Endwell</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01192 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Glens Falls</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01279 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01328 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Honeoye Falls</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01118 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Windsor</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01127 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01058 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01085 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01293 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01151 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vestal</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01188 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Westfield</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01271 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Burlington</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01264 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Calabash</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01168 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01108 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Elizabeth City</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01033 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01172 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01098 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01115 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01128 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01352 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rocky Mount</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01348 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01276 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tabor City</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01157 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01363 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01193 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Canal Fulton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01374 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Centerville</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01373 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01314 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01210 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01232 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01309 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01140 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01084 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sylvania</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01287 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01094 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01043 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01266 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ashland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01083 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01189 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01341 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01354 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01143 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Carnegie</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01320 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Downingtown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01323 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01257 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jefferson Hills</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01332 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Langhorne</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01075 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Norristown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01087 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01144 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01361 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01036 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pleasant Hills</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01106 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01156 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01204 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Warminster</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01338 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wyomissing</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01267 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cranston</city>
        <state>Rhode Island</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01214 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Johnston</city>
        <state>Rhode Island</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01340 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01066 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01217 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01303 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Easley</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01259 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Florence</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gaffney</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01077 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01093 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01295 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hodges</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01335 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Myrtle Beach</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01056 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rock Hill</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01294 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01126 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brentwood</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01220 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01324 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01342 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01096 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01050 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Corsicana</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01233 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01334 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01057 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01181 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01272 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01082 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01178 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01212 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01274 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Longview</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01116 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01262 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Richardson</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01055 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01182 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01186 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01353 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01215 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01223 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Midvale</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01079 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Abingdon</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01234 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01065 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01285 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01045 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ettrick</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01039 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01044 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01300 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01099 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Selah</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01069 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01145 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01185 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wenatchee</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01201 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oregon</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01344 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>West Allis</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Capital Federal</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Capital Federal</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Capital Federal</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Capital Federal</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Capital Federal</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Capital Federal</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Florencio Varela</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mar del Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mar del Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mendoza</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Monte Grande</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quilmes</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rosario</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rosario</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Miguel de Tucumán</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.54023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Miguel de Tucumán</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.61006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.61002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Woodville</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.61004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Box Hill</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.61003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Footscray</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.61001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Frankston</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.61005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.43002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Feldbach</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.43003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hallein</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.43005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Thalheim bei Wels</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Godinne</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gozée</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Halen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Linkebeek</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Merksem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Natoye</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tessenderlo</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.32004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zichem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Florianópolis</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Passo Fundo - RS</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Recife</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rio de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Río de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sao Pablo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.55007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35909 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35910 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35901 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35902 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35903 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35904 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35905 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35908 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35914 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35915 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35912 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Stara Zagora</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35906 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Veliko Turnovo</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11037 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11045 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11047 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spruce Grove</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11048 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11051 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Maple Ridge</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11033 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moncton</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11044 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Grand Falls-Windsor</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11053 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mount Pearl</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11042 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Corunna</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11049 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Courtice</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Downsview</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11050 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11040 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11035 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11054 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Richmond Hill</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11041 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11034 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11052 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Greenfield Park</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>La Malbaie</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Longueuil</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11043 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Point Claire</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Lambert</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Trois-Rivieres</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11036 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11039 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.11031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86038 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Changchun</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Changsha</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Changsha</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chengdu</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chengdu</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86034 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86035 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86036 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Foshan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haikou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nan Ning</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86037 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nanchang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nanjing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Qingdao</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Suzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86033 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Xi'An</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.86017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Xi'An</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.57002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.57004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.57005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.57006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bogotá</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.57001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Medellín</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38512 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cakovec</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38508 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dubrovnik</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38510 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Osijek</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38501 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rijeka</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38506 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sisak</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38502 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Split</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38503 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Split</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38504 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38505 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38507 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38509 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38511 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aarhus C</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Birkerød</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kolding</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>København NV</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>København S</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Odense C</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Roskilde</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rødovre</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rødovre</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Silkeborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Skive</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sønderborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Viby</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.45007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Værløse</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35801 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35804 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35808 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pori</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35805 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Porvoo</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35806 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tammisaari</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35802 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35803 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33087 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Albens</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33055 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33142 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33159 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Anzin</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33158 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Arras</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33084 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Avrillé</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33128 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Becon les Granits</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bersée</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beziers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33053 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bischheim</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Blois</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33043 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bort les Orgues</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33091 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bourg des cptes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33123 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Briollay</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33063 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Broglie</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33074 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bruay La Buissiere</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cannes Cedex</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33118 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cannes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chamalières</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33073 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chambery</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33059 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chateau Renault</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33089 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Colombey les Belles</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33099 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cournonterral</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33127 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cournonterral</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33162 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Croix</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dinard</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33110 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Donges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33094 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gambsheim</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33046 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33096 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hautmont</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33090 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hinx</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33145 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jarny</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33154 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>La Bouëxière</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33065 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>La Chapelle sur Erdre</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33102 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>La Montagne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33100 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>La Riche</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33058 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lambersart</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33098 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lambersart</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33103 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Levallois Perret</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33164 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Louvigne De bais</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33111 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Luynes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33136 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Marcq en Baroeul</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33115 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mondelange</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33088 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mont de Marsan</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33138 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mont de Marsan</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Montigny les Metz</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33163 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mundolsheim</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33109 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Murs Erigne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33108 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oignies</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ollioules</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33157 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Orthez</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33112 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Parcay les Pins</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33051 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33082 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33165 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33130 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pont à Mousson</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33122 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quarouble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33153 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rosiers d'Egletons</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33161 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rugles</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33126 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saint Alban Leysse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33140 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saint Aulaire</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33052 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saint Avertin</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saint Léger des Bois</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saintes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33148 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Salies de Bearn</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Savonnières</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33067 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Segre</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33040 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Serres Casset</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Six Four les Plages</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33160 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St Jouan des Guerets</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33079 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St Sebastien sur Loire</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33033 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33097 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33107 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Thouars</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33116 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tinténiac</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Toulon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33054 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33064 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33092 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33124 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33066 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vendôme</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33137 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vernoil</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vieux Condé</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33151 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vihiers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33077 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Villey St Etienne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.33135 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wattrelos</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.99501 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.99502 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.99503 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.99504 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.99505 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.99506 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.99507 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49096 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aschaffenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49130 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49161 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Backnang</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49173 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bad Kissingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49134 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bad Lippspringe</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49082 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bad Neustadt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49058 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bad Wörishofen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49145 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bamberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49072 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bensheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49048 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bergisch Gladbach</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49054 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49064 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49066 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49068 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49102 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49135 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49138 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49157 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49167 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49175 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49180 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49037 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49118 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49083 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brake</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49040 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bruchsal</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49089 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Celle</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49143 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cottbus</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49119 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Deggendorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49151 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dillingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49117 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Donaueschingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dortmund</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Düren</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49098 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Emden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Engelskirchen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ense</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49168 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49104 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Forchheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49070 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49147 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49137 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fulda</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49133 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Föhren</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49107 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gelnhausen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gütersloh</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hagen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49041 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hagen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49044 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49061 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49080 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49038 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49052 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49094 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49181 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49116 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Heilbronn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hemmingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Höchstädt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49136 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ingelheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49159 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Karlsruhe</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kassel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaufbeuren</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Koblenz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49047 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Käbschütztal-Krögis</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49146 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49114 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Landsberg am Lech</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49169 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Langen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49035 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49113 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49139 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49172 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49110 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leonberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49088 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49108 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Marburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49122 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Marburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49055 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Minden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49131 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Neumünster</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49132 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Neuruppin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49045 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Neuwied</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49062 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oranienburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49124 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oschersleben</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Paderborn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49053 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Potsdam</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49076 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Potsdam</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49049 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Radebeul</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49056 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rathenow</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Raubach</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rehau</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49142 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Reinfeld</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rhaunen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49184 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rheine</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49077 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rodgau-Dudenhofen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rüsselsheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49091 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rüsselsheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49042 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saarlouis</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49034 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Schwetzingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Solingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49057 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Solingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49078 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49099 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49043 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wallerfing</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49067 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wardenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49165 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Warendorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49051 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Weinheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49127 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Weyhe</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49092 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wiesloch</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Witten</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Witten</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49095 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wolfsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.49060 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zerbst</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Heraklion</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kalamaria</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kavala</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lamia</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nafplio</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rethymno</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Serres</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.30009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50205 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guatemala</city>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50206 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guatemala</city>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50203 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nivel 12</city>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50201 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nivel Guatemala</city>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50202 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nivel Guatemala</city>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50204 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nivel Guatemala</city>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50207 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quetzaltenango</city>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Baja</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Debrecen</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Debrecen</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Debrecen</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Deszk</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dombovar</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Erd</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Farkasgyepü</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Györ</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hajduböszörmeny</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hodmezovasarhely</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaposvar</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kapuvar</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kecskemet</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Makó</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mohacs</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mosonmagyarovar</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nagykanizsa</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nyiregyhaza</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pecs</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pecs</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Siófok</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Szarvas</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Szeged</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tatabanya</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Törökbálint</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.36025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Törökbálint</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ahmedabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chennai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coimbatore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coimbatore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dadar(East)</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jaipur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jaipur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jaipur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jaipur</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Karnataka</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Maharashtra</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Maharastra</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.91011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Punjab</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35307 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Co. Cork</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35306 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Co. Tipperary</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35305 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Co. Wexford</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35301 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dublin 24</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35302 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35303 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Limerick</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35308 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Limerick</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35304 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Offaly</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.97207 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.97204 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beer Sheva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.97208 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.97202 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.97206 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.97203 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Petach Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.97201 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.97205 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Arenzano (ge)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ascoli Piceno</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Avellino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Benevento</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Busto Arsizio (va)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Catanzaro</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chieti Scalo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Monza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Orbassano (to)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Orbassano (to)</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Prato</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Reggio Emilia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.39023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Treviso</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Daejoen</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gangwon-Do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Goyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jeonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.82019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Uijeongbu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37106 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Daugavpils</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37107 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Daugavpils</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37108 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Daugavpils</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37102 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kraslava</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37104 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37109 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37110 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Talsi</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37103 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Valmiera</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Alytus</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaunas</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaunas</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Klaipeda</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Siauliai</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Utena</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.37010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.60006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Johor Bahru</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.60001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.60002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.60004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.60008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pahang</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.60005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sarawak</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.60009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Selangor</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.60007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Terengganu</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.52004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aguascalientes</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.52007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Distrito Federal</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.52005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Guadalajara</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.52002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Monte Rey</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.52001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>México</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.52003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zona Río</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Almere</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Andijk</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beek En Donk</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Beek</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ermelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hoogwoud</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nijverdal</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oude Pekela</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.31005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Roelofarendsveen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.64004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Christchurch</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.64003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dunedin</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.64002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Newtown Wellington NZ</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.64001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tauranga</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Drammen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fredrikstad</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hønefoss</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kløfta</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kolbjørnsvik</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Løvenstad</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sandvika</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Svelvik</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.47006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Trollåsen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50703 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Carrasquilla</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50701 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Marbella</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.50702 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Marbella</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.51002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bellavista</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.51003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cusco</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.51004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jesús Maria</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.51007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Jesús María</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.51005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.51001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Isidro</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.51006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Martin de Porres</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.63004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cavite City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.63002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Davao City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.63003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Iloilo City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.63006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Iloilo City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.63001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.63008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Manila</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.63005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.63007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Babice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bialystok</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bialystok</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Checiny</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gdansk</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gdynia</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48037 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gorzow Wlkp</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ilawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48033 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Katowice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48039 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Katowice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48044 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Katowice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48048 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48043 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Libiaz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48051 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48056 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48059 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Olsztyn</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ostrow Wielkopolska</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Piaseczno</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48040 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Piaseczno</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Poznan</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Poznan</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48058 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Poznan</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48060 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rokietnica</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Skierniewice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Slawkow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48036 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Szczecin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48045 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tarnow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48057 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tczew</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Torun</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tranow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48053 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Turek</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48034 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48042 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48049 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wolomin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48035 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48038 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Wroclaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.48022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zakopane</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35103 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Amadora</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35102 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coimbra</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35107 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35108 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Matosinhos</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Penafiel</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35106 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vila Nova de Gaia</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.35104 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Viseu</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01177 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ponce</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.01162 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Juan</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brasov</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brasov</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bucuresti</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Constanta</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.40006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Craiova</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Arkhangelsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07049 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Barnaul</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07054 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Barnaul</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07053 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chelyabinsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ekaterinburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07038 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gatchina (Leningradskaya oblast)</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07036 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Irkutsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ivanovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaliningrad</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kazan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kazan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kazan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07048 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kemerovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07060 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kemerovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07059 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kirov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krasnodar</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Krasnodar</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07029 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07043 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07045 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Murmansk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07055 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nizhniy Novgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07051 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nizhny Novgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07037 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07040 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07042 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07041 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Penza</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07050 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pskov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rostov-na-Donu</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rostov-on-Don</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07039 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ryazan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07034 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Samara</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07047 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Saratov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07033 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07046 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07052 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tomsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07035 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tomsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07057 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tomsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Velikiy Novgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.07044 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Yaroslavl</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38103 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38104 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38106 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38107 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38102 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kragujevac</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nis</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sremska Kamenica</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42103 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bardejov</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42107 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bratislava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42102 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Humenne</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42105 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kosice</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42111 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kosice</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42113 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kosice</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42108 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Levice</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42109 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Martin</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42112 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Poprad</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42101 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Presov</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42104 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Rimavska Sobota</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42106 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spisska Nova Ves</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.42110 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sturovo</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Amanzimtoti</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bellville</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bloemfontein</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Centurion</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pretoria</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.27007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Somerset West</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Badajoz</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Badalona (Barcelona)</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34025 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Centelles</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Cáceres</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Elda</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lugo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mérida</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Plasencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Pozuelo de Alarcón</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>San Juan de Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Terrassa (Barcelona)</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Torrevieja</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vic (Barcelona)</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vilanova i la Geltrú</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.34004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Brämhult</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Eksjö</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gullspång</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Göteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Höllviken</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Järfälla</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kil</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lidingö</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Luleå</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Sigtuna</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Solna</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Uddevalla</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.46006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ascona</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Glarus</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Gossau</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Liestal</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Locarno</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Lugano</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Spiez</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Gallen</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41009 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St. Gallen</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.41014 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88607 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Changhua</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88614 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chia-Yi</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88608 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaohsiung City</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88609 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaohsiung City</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88611 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88604 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>New Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88605 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88606 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88612 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88610 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88602 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88603 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88613 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.88601 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Taoyuan County</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.66004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chiang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.66003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hatyai, Songkhla</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.66002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Khon Kaen</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.66005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Muang, Phitsanulok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.66001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nonthaburi</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21603 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ariana</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21605 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ariana</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21606 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ariana</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21607 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ariana</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21610 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Mahdia</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21609 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Monastir</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21608 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nabeul</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21601 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tunis</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21602 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tunis</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.21604 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Tunis</city>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Adana</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Antalya</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Aydin</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Bolu</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Edirne</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Erzurum</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Hatay</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90021 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90016 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.90007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Malatya</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38028 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Crimea</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38024 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dnipropetrovks</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38022 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dnipropetrovsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38034 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Dnyepropyetrovsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Donetsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38020 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Donetsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38018 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38012 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38013 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38015 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38032 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38026 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Nikolayev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38023 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Odesa</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38027 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Odessa</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38031 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Odessa</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38017 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Simferopol</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38019 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Vinnytsya</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.38030 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Zaporizhzhya</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44010 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Atherstone</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44008 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Burbage</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44004 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chertsey</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44002 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Chesterfield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44003 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Coventry</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44001 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Exeter</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44007 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Fowey</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44005 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Frome</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44011 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>Leamington Spa</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>205.452.44006 Boehringer Ingelheim Investigational Site</name>
      <address>
        <city>St Just, Penzance</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Croatia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Georgia</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Guatemala</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Panama</country>
    <country>Peru</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Puerto Rico</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Tunisia</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Chile</country>
    <country>Morocco</country>
  </removed_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2010</study_first_submitted>
  <study_first_submitted_qc>May 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2010</study_first_posted>
  <results_first_submitted>May 20, 2014</results_first_submitted>
  <results_first_submitted_qc>May 20, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 20, 2014</results_first_posted>
  <last_update_submitted>May 20, 2014</last_update_submitted>
  <last_update_submitted_qc>May 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tiotropium Bromide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>This table summarizes study treatment disposition and reasons for discontinuation of study medication. Deaths that caused discontinuation from trial medications are included in AEs. Lost to follow−up indicates status at time of discontinuation of trial medication. Vital status was ascertained for 99.7% of patients.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Tiotropium 2.5 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
        </group>
        <group group_id="P2">
          <title>Tiotropium 5 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
        </group>
        <group group_id="P3">
          <title>Tiotropium 18 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5741"/>
                <participants group_id="P2" count="5729"/>
                <participants group_id="P3" count="5713"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4400">See Pre-Assignment Details above for comments.</participants>
                <participants group_id="P2" count="4399">See Pre-Assignment Details above for comments.</participants>
                <participants group_id="P3" count="4400">See Pre-Assignment Details above for comments.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1341"/>
                <participants group_id="P2" count="1330"/>
                <participants group_id="P3" count="1313"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Not treated</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Sites with data irregularities/fraud</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="602"/>
                <participants group_id="P2" count="606"/>
                <participants group_id="P3" count="635"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="60"/>
                <participants group_id="P3" count="59"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="66"/>
                <participants group_id="P3" count="41"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="63"/>
                <participants group_id="P3" count="55"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="331"/>
                <participants group_id="P2" count="335"/>
                <participants group_id="P3" count="319"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other reason not specified</title>
              <participants_list>
                <participants group_id="P1" count="210"/>
                <participants group_id="P2" count="176"/>
                <participants group_id="P3" count="178"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Treated set (TS): This analysis set included all randomized subjects without data irregularities who were documented to have taken at least one dose of investigational treatment.</population>
      <group_list>
        <group group_id="B1">
          <title>Tiotropium 2.5 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
        </group>
        <group group_id="B2">
          <title>Tiotropium 5 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
        </group>
        <group group_id="B3">
          <title>Tiotropium 18 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5724"/>
            <count group_id="B2" value="5705"/>
            <count group_id="B3" value="5687"/>
            <count group_id="B4" value="17116"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.1" spread="9.1"/>
                    <measurement group_id="B2" value="64.9" spread="9.1"/>
                    <measurement group_id="B3" value="65.0" spread="9.0"/>
                    <measurement group_id="B4" value="65.0" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1656"/>
                    <measurement group_id="B2" value="1571"/>
                    <measurement group_id="B3" value="1652"/>
                    <measurement group_id="B4" value="4879"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4068"/>
                    <measurement group_id="B2" value="4134"/>
                    <measurement group_id="B3" value="4035"/>
                    <measurement group_id="B4" value="12237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to All-Cause Mortality</title>
        <description>Number of patients with all-cause mortality</description>
        <time_frame>Up to 3 years</time_frame>
        <population>Death analysis set (DAS) including vital status follow-up: This analysis set included all randomized subjects excluding only subjects who were documented as not treated.</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Time to All-Cause Mortality</title>
          <description>Number of patients with all-cause mortality</description>
          <population>Death analysis set (DAS) including vital status follow-up: This analysis set included all randomized subjects excluding only subjects who were documented as not treated.</population>
          <units>Number of deaths</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5730"/>
                <count group_id="O2" value="5711"/>
                <count group_id="O3" value="5694"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="440" spread="7.7"/>
                    <measurement group_id="O2" value="423" spread="7.4"/>
                    <measurement group_id="O3" value="439" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>H0: Hazard Ratio for Respimat/HandiHaler &gt;= 1.25 Ha: Hazard Ratio for Respimat/HandiHaler &lt; 1.25</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Three tests were conducted in hierarchical order. Non-inferiority of time to death from any cause was tested on the two Respimat doses: Tio R 5 vs. Tio HH18, then if non-inferiority was achieved Tio R 2.5 vs Tio HH18. If successful, a test of superiority of Tio R5 over Tio HH18 for time to first COPD exacerbation was conducted. The non-inferiority delta for time to death was 1.25. Non-inferiority tests were performed at one-sided α=0.025 level. Superiority test was performed at two sided α=0.05.</non_inferiority_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.957</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.837</ci_lower_limit>
            <ci_upper_limit>1.094</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>H0: Hazard Ratio for Respimat/HandiHaler &gt;= 1.25 Ha: Hazard Ratio for Respimat/HandiHaler &lt; 1.25</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Three tests were conducted in hierarchical order. Non-inferiority of time to death from any cause was tested on the two Respimat doses: Tio R 5 vs. Tio HH18, then if non-inferiority was achieved Tio R 2.5 vs Tio HH18. If successful, a test of superiority of Tio R5 over Tio HH18 for time to first COPD exacerbation was conducted. The non-inferiority delta for time to death was 1.25. Non-inferiority tests were performed at one-sided α=0.025 level. Superiority test was performed at two sided α=0.05.</non_inferiority_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.996</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.872</ci_lower_limit>
            <ci_upper_limit>1.136</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to First COPD Exacerbation</title>
        <description>Defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).
&quot;Onset of exacerbation&quot; was defined by the onset of first recorded symptom. The &quot;end of exacerbation&quot; was decided by the investigator based on clinical judgement.
Exacerbations were classified as follows:
Mild:a new prescription of maintenance bronchodilator only Moderate:antibiotics or systemic steroids without hospitalization Severe:hospitalization.</description>
        <time_frame>Up to 3 years</time_frame>
        <population>Treated set (TS, on-treatment only)</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First COPD Exacerbation</title>
          <description>Defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).
&quot;Onset of exacerbation&quot; was defined by the onset of first recorded symptom. The &quot;end of exacerbation&quot; was decided by the investigator based on clinical judgement.
Exacerbations were classified as follows:
Mild:a new prescription of maintenance bronchodilator only Moderate:antibiotics or systemic steroids without hospitalization Severe:hospitalization.</description>
          <population>Treated set (TS, on-treatment only)</population>
          <units>days to event</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5724"/>
                <count group_id="O2" value="5705"/>
                <count group_id="O3" value="5687"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="707" lower_limit="662" upper_limit="750"/>
                    <measurement group_id="O2" value="756" lower_limit="692" upper_limit="816"/>
                    <measurement group_id="O3" value="719" lower_limit="672" upper_limit="777"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>H0: Hazard Ratio for Respimat/HandiHaler = 1 Ha: Hazard Ratio for Respimat/HandiHaler ≠ 1
at alpha = 0.05</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4194</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.978</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.928</ci_lower_limit>
            <ci_upper_limit>1.032</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>H0: Hazard Ratio for Respimat/HandiHaler = 1 Ha: Hazard Ratio for Respimat/HandiHaler ≠ 1
at alpha = 0.05</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.5593</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.016</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.964</ci_lower_limit>
            <ci_upper_limit>1.070</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>H0: Hazard Ratio for Respimat/HandiHaler = 1 Ha: Hazard Ratio for Respimat/HandiHaler ≠ 1
at alpha = 0.05</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1639</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.038</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.985</ci_lower_limit>
            <ci_upper_limit>1.094</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Trough FEV1 Over 120 Weeks (in a Substudy of 1370 Patients)</title>
        <description>Trough forced expiratory volume in one second (FEV1) over 120 weeks (in a substudy of 1370 patients)</description>
        <time_frame>Up to 3 years</time_frame>
        <population>SSS - PFT - Sub-study set (pulmonary function testing). This analysis set included all subjects in the TS who signed informed consent to participate in the spirometry sub-study and had at least baseline and one on-treatment trough FEV1.</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Trough FEV1 Over 120 Weeks (in a Substudy of 1370 Patients)</title>
          <description>Trough forced expiratory volume in one second (FEV1) over 120 weeks (in a substudy of 1370 patients)</description>
          <population>SSS - PFT - Sub-study set (pulmonary function testing). This analysis set included all subjects in the TS who signed informed consent to participate in the spirometry sub-study and had at least baseline and one on-treatment trough FEV1.</population>
          <units>Liter</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="464"/>
                <count group_id="O2" value="461"/>
                <count group_id="O3" value="445"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.258" spread="0.012"/>
                    <measurement group_id="O2" value="1.285" spread="0.012"/>
                    <measurement group_id="O3" value="1.295" spread="0.012"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>FEV1 was analyzed through Week 120 using REML-based repeated measures.
H0: Adjusted mean difference for Respimat/HandiHaler ≥ 50ml Ha: Adjusted mean difference for Respimat/HandiHaler &lt; 50 ml</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The first test performed was to test the main effect for treatment in the mixed model repeated measures (MMRM) model, specifically the 95% CI for the contrast between Tio R 5ug and Tio HH 18ug was compared to the non-inferiority delta of 50 mL. If that test was successful, the second test in the hierarchy was to test the main effect for treatment in the MMRM model, specifically the 95% CI for the contrast between Tio R 2.5 ug and Tio HH 18 ug was compared to the non-inferiority delta of 50 mL.</non_inferiority_desc>
            <param_type>Adjusted mean difference</param_type>
            <param_value>-.010</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.014</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-.038</ci_lower_limit>
            <ci_upper_limit>0.018</ci_upper_limit>
            <estimate_desc>Model included the fixed, categorical effects of treatment, investigative site, visit, and treatment-by-visit interaction, and continuous, fixed covariates of baseline and baseline-by-visit interaction, and a random term of patient.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>FEV1 was analyzed through Week 120 using REML-based repeated measures.
H0: Adjusted mean difference for Respimat/HandiHaler ≥ 50ml Ha: Adjusted mean difference for Respimat/HandiHaler &lt; 50 ml</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The first test performed was to test the main effect for treatment in the mixed model repeated measures (MMRM) model, specifically the 95% CI for the contrast between Tio R 5ug and Tio HH 18ug was compared to the non-inferiority delta of 50 mL. If that test was successful, the second test in the hierarchy was to test the main effect for treatment in the MMRM model, specifically the 95% CI for the contrast between Tio R 2.5 ug and Tio HH 18 ug was compared to the non-inferiority delta of 50 mL.</non_inferiority_desc>
            <param_type>Adjusted mean difference</param_type>
            <param_value>-.037</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.014</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-.065</ci_lower_limit>
            <ci_upper_limit>-.009</ci_upper_limit>
            <estimate_desc>Model included the fixed, categorical effects of treatment, investigative site, visit, and treatment-by-visit interaction, and continuous, fixed covariates of baseline and baseline-by-visit interaction, and a random term of patient.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of COPD Exacerbations</title>
        <description>The number of COPD exacerbations. COPD exacerbation defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).</description>
        <time_frame>Up to 3 years</time_frame>
        <population>Treated Set - on treatment only</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Number of COPD Exacerbations</title>
          <description>The number of COPD exacerbations. COPD exacerbation defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).</description>
          <population>Treated Set - on treatment only</population>
          <units>number of COPD exacerbations</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5724"/>
                <count group_id="O2" value="5705"/>
                <count group_id="O3" value="5687"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6565"/>
                    <measurement group_id="O2" value="6425"/>
                    <measurement group_id="O3" value="6504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.8330</p_value>
            <method>Negative binomial regression</method>
            <param_type>Rate ratio of events</param_type>
            <param_value>1.01</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.03</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.95</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.8047</p_value>
            <method>Negative binomial regression</method>
            <param_type>Rate ratio of events</param_type>
            <param_value>0.99</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.03</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.94</ci_lower_limit>
            <ci_upper_limit>1.05</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6468</p_value>
            <method>Negative binomial regression</method>
            <param_type>Rate ratio of events</param_type>
            <param_value>1.01</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.03</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.96</ci_lower_limit>
            <ci_upper_limit>1.07</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Hospitalization Associated With COPD Exacerbation</title>
        <description>The results presented below are for the patients with hospitalizations due to COPD exacerbations.</description>
        <time_frame>Up to 3 years</time_frame>
        <population>treated set - on-treatment only</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Hospitalization Associated With COPD Exacerbation</title>
          <description>The results presented below are for the patients with hospitalizations due to COPD exacerbations.</description>
          <population>treated set - on-treatment only</population>
          <units>Number of patients with event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5724"/>
                <count group_id="O2" value="5705"/>
                <count group_id="O3" value="5687"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="869"/>
                    <measurement group_id="O2" value="826"/>
                    <measurement group_id="O3" value="811"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1762</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.068</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.971</ci_lower_limit>
            <ci_upper_limit>1.176</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6384</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.024</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.929</ci_lower_limit>
            <ci_upper_limit>1.128</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3784</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.044</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.949</ci_lower_limit>
            <ci_upper_limit>1.148</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Hospitalizations Associated With COPD Exacerbation</title>
        <description>Total number of hospitalizations associated with COPD exacerbation.</description>
        <time_frame>Up to 3 years</time_frame>
        <population>treated set - on treatment only</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Hospitalizations Associated With COPD Exacerbation</title>
          <description>Total number of hospitalizations associated with COPD exacerbation.</description>
          <population>treated set - on treatment only</population>
          <units>number of hospitalizations</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5724"/>
                <count group_id="O2" value="5705"/>
                <count group_id="O3" value="5687"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1316"/>
                    <measurement group_id="O2" value="1284"/>
                    <measurement group_id="O3" value="1216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1255</p_value>
            <p_value_desc>p-value from negative binomial regression.</p_value_desc>
            <method>Negative binomial regression</method>
            <param_type>Rate ratio of events</param_type>
            <param_value>1.09</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.06</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.98</ci_lower_limit>
            <ci_upper_limit>1.22</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3441</p_value>
            <p_value_desc>p-value from negative binomial regression.</p_value_desc>
            <method>Negative binomial regression</method>
            <param_type>Rate ratio of events</param_type>
            <param_value>1.06</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.06</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.94</ci_lower_limit>
            <ci_upper_limit>1.18</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.5573</p_value>
            <p_value_desc>p-value from negative binomial regression.</p_value_desc>
            <method>Negative binomial regression</method>
            <param_type>Rate ratio of events</param_type>
            <param_value>1.03</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.06</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>1.16</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Moderate to Severe COPD Exacerbation</title>
        <description>COPD exacerbation defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).
Exacerbations classified as follows:
Mild:a new prescription of maintenance bronchodilator only Moderate:antibiotics or systemic steroids without hospitalization Severe:hospitalization.
Results presented below are number of patients with moderate to severe exacerbations.</description>
        <time_frame>Up to 3 years</time_frame>
        <population>treated set - on treatment only</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Moderate to Severe COPD Exacerbation</title>
          <description>COPD exacerbation defined as &quot;a complex of lower respiratory events/symptoms (increase of new onset) related to the underlying COPD, with duration of three days or more, requiring a change in treatment&quot; where a &quot;complex of lower respiratory event/symptoms&quot; was defined as having at least two of the following: shortness of breath, sputum production (volume), occurrence of purulent sputum, cough, wheezing, chest tightness and where &quot;a required change in treatment&quot; includes the following:Prescription of antibiotics and/or systemic steroids, and/or a newly prescribed maintenance respiratory medication (i.e., bronchodilators including theophyllines).
Exacerbations classified as follows:
Mild:a new prescription of maintenance bronchodilator only Moderate:antibiotics or systemic steroids without hospitalization Severe:hospitalization.
Results presented below are number of patients with moderate to severe exacerbations.</description>
          <population>treated set - on treatment only</population>
          <units>number of patients with event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5724"/>
                <count group_id="O2" value="5705"/>
                <count group_id="O3" value="5687"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2769"/>
                    <measurement group_id="O2" value="2694"/>
                    <measurement group_id="O3" value="2732"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6823</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.011</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.959</ci_lower_limit>
            <ci_upper_limit>1.066</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.5377</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.983</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.932</ci_lower_limit>
            <ci_upper_limit>1.037</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3048</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.028</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.975</ci_lower_limit>
            <ci_upper_limit>1.084</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Onset of First Major Adverse Cardiovascular Event (MACE)</title>
        <description>Time to onset of first major adverse cardiovascular event (MACE). MACE was defined as: Fatal event in the system organ classes of cardiac and vascular disorders, Preferred terms: sudden death, cardiac death, sudden cardiac death, Outcome events of myocardial infarction (serious and non-serious), Outcome events of stroke (serious and non-serious) and Outcome events of TIA (serious and non-serious). The results presented below are for the number of patients with MACE.</description>
        <time_frame>Up to 3 years</time_frame>
        <population>Treated set - on treatment only</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Onset of First Major Adverse Cardiovascular Event (MACE)</title>
          <description>Time to onset of first major adverse cardiovascular event (MACE). MACE was defined as: Fatal event in the system organ classes of cardiac and vascular disorders, Preferred terms: sudden death, cardiac death, sudden cardiac death, Outcome events of myocardial infarction (serious and non-serious), Outcome events of stroke (serious and non-serious) and Outcome events of TIA (serious and non-serious). The results presented below are for the number of patients with MACE.</description>
          <population>Treated set - on treatment only</population>
          <units>number of patients with MACE</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5724"/>
                <count group_id="O2" value="5705"/>
                <count group_id="O3" value="5687"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="224"/>
                    <measurement group_id="O2" value="222"/>
                    <measurement group_id="O3" value="202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Causes of death from MACE were determined by adjudication.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3043</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.105</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.913</ci_lower_limit>
            <ci_upper_limit>1.336</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Causes of death from MACE were determined by adjudication.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3263</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.100</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.909</ci_lower_limit>
            <ci_upper_limit>1.331</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Causes of death from MACE were determined by adjudication.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.9644</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.004</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.834</ci_lower_limit>
            <ci_upper_limit>1.209</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Death From Major Adverse Cardiovascular Event (MACE)</title>
        <description>The results presented below are number of patients with death from MACE.</description>
        <time_frame>Up to 3 years</time_frame>
        <population>TS including vital status follow−up, DAS</population>
        <group_list>
          <group group_id="O1">
            <title>Tiotropium 2.5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
          </group>
          <group group_id="O2">
            <title>Tiotropium 5 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
          </group>
          <group group_id="O3">
            <title>Tiotropium 18 mcg and Placebo</title>
            <description>Patients receive one of the active tiotropium arms daily
tiotropium 18 mcg: HandiHaler</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Death From Major Adverse Cardiovascular Event (MACE)</title>
          <description>The results presented below are number of patients with death from MACE.</description>
          <population>TS including vital status follow−up, DAS</population>
          <units>Number of deaths from MACE</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5730"/>
                <count group_id="O2" value="5711"/>
                <count group_id="O3" value="5694"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="119"/>
                    <measurement group_id="O2" value="113"/>
                    <measurement group_id="O3" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Time to death from MACE was analyzed using the full study duration including vital status follow-up.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2439</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.171</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.898</ci_lower_limit>
            <ci_upper_limit>1.526</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Time to death from MACE was analyzed using the full study duration including vital status follow-up.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4413</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.111</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.850</ci_lower_limit>
            <ci_upper_limit>1.453</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Time to death from MACE was analyzed using the full study duration including vital status follow-up.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6910</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.054</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.814</ci_lower_limit>
            <ci_upper_limit>1.363</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From the first drug intake up to 30 days after administration</time_frame>
      <desc>Prospectively defined outcome events, serious adverse events, adverse events leading to discontinuation, and investigator-determined drug-related adverse events were required for collection in this trial.</desc>
      <group_list>
        <group group_id="E1">
          <title>Tiotropium 2.5 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
tiotropium 1.25 mcg (2 actuations/day): soft mist inhaler 2 actuations=2 puffs/day</description>
        </group>
        <group group_id="E2">
          <title>Tiotropium 5 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
tiotropium 2.5 mcg (2 actuations/day): soft mist inhaler (2 actuations=2 puffs/day)</description>
        </group>
        <group group_id="E3">
          <title>Tiotropium 18 mcg and Placebo</title>
          <description>Patients receive one of the active tiotropium arms daily
Tiotropium 18 mcg: HandiHaler</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MEDDRA 16.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1932" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1876" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1928" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypercoagulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy mediastinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pernicious anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Polycythaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thrombocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Adams-Stokes syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic valve disease mixed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="32" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bundle branch block right</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac valve disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cor pulmonale acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cor pulmonale chronic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diastolic dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="39" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Postinfarction angina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prinzmetal angina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Silent myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Alpha-1 anti-trypsin deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Congenital absence of bile ducts</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hamartoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Inappropriate antidiuretic hormone secretion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Amaurosis fugax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lens dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Open angle glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Retinal infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Strabismus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ulcerative keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abdominal hernia obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abdominal wall haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colonic fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colonic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Duodenal scarring</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Duodenal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Duodenogastric reflux</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Enterocutaneous fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Epiploic appendagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Femoral hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastritis atrophic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroduodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrointestinal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrooesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Inguinal hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intestinal mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intestinal polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Jejunal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Large intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lumbar hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malabsorption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Megacolon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mesenteric artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mouth haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Obstruction gastric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophageal food impaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophageal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophagitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancreatitis necrotising</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancreatolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Papilla of Vater stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Parotid gland enlargement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peptic ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pharyngo-oesophageal diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Proctocolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Reflux gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Retroperitoneal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Umbilical hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Condition aggravated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Device lead damage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Drowning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Exercise tolerance decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hernia obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Implant site calcification</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Implant site inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Multi-organ disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vessel puncture site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Alcoholic liver disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Biliary cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gallbladder perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatorenal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Non-alcoholic steatohepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Autoimmune disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Food allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abscess intestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acinetobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Amoebic dysentery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Appendiceal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atypical mycobacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atypical pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bacterial toxaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bursitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Campylobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cellulitis of male external genital organ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chronic hepatitis C</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Clostridium colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colon gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Eczema infected</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Enterobacter pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Enterococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Enterocolitis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Enterocolitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Febrile infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gallbladder empyema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroenteritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroenteritis clostridial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Groin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>H1N1 influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Helicobacter gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic cyst infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatitis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Herpes virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Herpes zoster ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Herpes zoster oticus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Klebsiella infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lyme disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mastitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Measles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Neutropenic sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nosocomial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pelvic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Perineal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pertussis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumocystis jiroveci infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="339" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="344" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="340" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia influenzal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia legionella</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia necrotising</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia pseudomonas aeruginosa</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Postoperative abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pseudomonas bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Psoas abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Purulence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pyoderma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pyonephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Scrotal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Serratia infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urethral abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary tract infection staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Viral diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal wound dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anastomotic leak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arterial restenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Burns second degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cataract operation complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chemical poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Comminuted fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Endotracheal intubation complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Foreign body</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fractured coccyx</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Incisional hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Injury corneal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Limb crushing injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Open fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumoconiosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonitis chemical</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Post lumbar puncture syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Post procedural contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Post procedural myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Scar</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin graft failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal column injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal cord injury cervical</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Splinter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Traumatic lung injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urethral injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vascular graft occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Wound secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Angiogram</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arteriogram coronary normal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arthroscopy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Biopsy lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Biopsy vocal cord normal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chest X-ray abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fibrin D dimer increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Full blood count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>International normalised ratio abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Investigation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laparoscopy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Troponin I increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diabetes with hyperosmolarity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Feeding disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Glucose tolerance impaired</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypophagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lactic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bone infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bursa disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diastasis recti abdominis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Facet joint syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fracture malunion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Fracture nonunion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Joint ankylosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Knee deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Kyphosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mixed connective tissue disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spondyloarthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acoustic neuroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acral lentiginous melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Adenoma benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Angiosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anogenital warts</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>B-cell unclassifiable lymphoma low grade</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of adrenal gland</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of urethra</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Benign ovarian tumour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Benign salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder adenocarcinoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage 0, with cancer in situ</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bone cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bone neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bowen's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Brain cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Breast cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Breast cancer stage II</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchial neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour pulmonary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac myxoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastric adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastric neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrointestinal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrointestinal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastrointestinal tract adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Glioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Invasive lobular breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Large cell lung cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Large intestine benign neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laryngeal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laryngeal squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lip squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage IV</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="52" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="60" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="48" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage III</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of ampulla of Vater</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of unknown primary site</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malignant palate neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Malignant splenic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mediastinum neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to adrenals</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to kidney</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to muscle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to peritoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to retroperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to spine</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastases to spleen</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastatic bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastatic gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Monoclonal gammopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasal cavity cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasopharyngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasopharyngeal cancer stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasopharyngeal neoplasm benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Neoplasm prostate</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma of the skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oesophageal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oral neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oropharyngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oropharyngeal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pancreatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pharyngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pleural mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pleural neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage II</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rectal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Salivary gland cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Signet-ring cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Small cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Splenic marginal zone lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of pharynx</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the hypopharynx</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the oral cavity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the tongue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Throat cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thymoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tumour necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary tract carcinoma in situ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vaginal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vascular neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vocal cord neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vulval cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Brain hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cauda equina syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebellar ataxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebral arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebral artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebral thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebrosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cerebrovascular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cervical myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Complicated migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Demyelinating polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Facial spasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Grand mal convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hemiplegia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypertonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intercostal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intracranial haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Motor dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nervous system disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peripheral nerve lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Post herpetic neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Quadriplegia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Radial nerve palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ruptured cerebral aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal cord infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal cord ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tongue biting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tonic convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ulnar tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>VIIth nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vocal cord paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Alcoholic psychosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Drug abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mania</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mental disorder due to a general medical condition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Substance abuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder neck obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder outlet obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Calculus urethral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ketonuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Postrenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired phimosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ovarian mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostatic dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostatic obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spermatic cord inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchopleural fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchopneumopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bullous lung disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="895" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="868" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="851" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Chronic respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dyspnoea paroxysmal nocturnal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Epiglottic cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laryngeal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laryngeal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laryngeal leukoplakia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Laryngeal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mediastinal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Organising pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pharyngeal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pharyngeal polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pharyngeal ulceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pleural calcification</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pleural fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pleural fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary cavitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Respiratory acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Respiratory disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sinus polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vocal cord cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vocal cord polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vocal cord thickening</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dermatitis exfoliative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Erythema nodosum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Henoch-Schonlein purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peau d'orange</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pyoderma gangrenosum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin discolouration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Stasis dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Subcutaneous emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Abstains from alcohol</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac assistance device user</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Angioplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic valve repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic valve replacement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Appendicectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arterial repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arterial stent insertion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bladder operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bone graft</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bone operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac ablation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker removal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker replacement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Central venous catheterisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Cholecystostomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colon operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Colostomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coronary arterial stent insertion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coronary artery bypass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coronary endarterectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Coronary revascularisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Dental implantation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Ear operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Elective surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Endobronchial valve implantation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Frontal sinus operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gallbladder operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Gastroenterostomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemorrhoid operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Heart valve operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Heart valve replacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hip surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hysterectomy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hysterosalpingo-oophorectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator insertion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator replacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intervertebral disc operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Large intestine anastomosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Leg amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Limb operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung transplant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lung volume reduction surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Mechanical ventilation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Medical device change</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Medical device removal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Nasal septal operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Obesity surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Partial lung resection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peripheral artery bypass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Polypectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prophylaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostatectomy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prostatic operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Prosthesis implantation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Pulmonary valve replacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rehabilitation therapy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Respiratory therapy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Rotator cuff repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Salpingo-oophorectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Shoulder arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Shoulder operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Skin operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal fusion surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal laminectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Spinal operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Stem cell transplant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Stent placement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thyroidectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Transurethral bladder resection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Transurethral prostatectomy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urethral operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Urethrotomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vaginoplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vascular graft</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vascular stent insertion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aneurysm ruptured</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arterial disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arterial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arterial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Arteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Bleeding varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Jugular vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Leriche syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Post thrombotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Steal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Subclavian vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vascular occlusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Vasodilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Venous insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5687"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MEDDRA 16.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1932" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1876" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1928" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="1932" subjects_at_risk="5724"/>
                <counts group_id="E2" subjects_affected="1876" subjects_at_risk="5705"/>
                <counts group_id="E3" subjects_affected="1928" subjects_at_risk="5687"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Prospectively defined outcome events, serious adverse events, adverse events leading to discontinuation, and investigator-determined drug-related adverse events were required for collection in this trial.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Boehringer Ingelheim Call Center</name_or_title>
      <organization>Boehringer Ingelheim Pharmaceuticals</organization>
      <phone>1-800-243-0127</phone>
      <email>clintriage.rdg@boehringer-ingelheim.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

